Table 3.
Incidence of testicular germ cell tumors by race/ethnicity and year of diagnosis, USCS Registries, 2001–2016
| Testicular germ cell tumors | Seminoma | Nonseminoma | ||||
|---|---|---|---|---|---|---|
| Count | Rate (95% CI) † | Count | Rate (95% CI) † | Count | Rate (95% CI) † | |
| NHW | ||||||
| 2001–2004 | 24,516 | 6.43 (6.35–6.52) | 14,697 | 3.81 (3.75–3.87) | 9,619 | 2.57 (2.52–2.63) |
| 2005–2008 | 24,882 | 6.63 (6.55–6.71) | 14,649 | 3.87 (3.81–3.94) | 10,043 | 2.71 (2.66–2.77) |
| 2009–2012 | 24,623 | 6.65 (6.57–6.74) | 14,271 | 3.85 (3.78–3.91) | 10,137 | 2.76 (2.70–2.81) |
| 2013–2016 | 25,041 | 6.79 (6.70–6.87) | 14,356 | 3.89 (3.83–3.96) | 10,483 | 2.85 (2.80–2.91) |
| APC | 0.41 | 0.14 | 0.82 | |||
| p-value | p<0.01 | p=0.22 | p<0.01 | |||
| Hispanic | ||||||
| 2001–2004 | 3,429 | 3.63 (3.50–3.76) | 1,746 | 2.01 (1.91–2.12) | 1,669 | 1.59 (1.51–1.67) |
| 2005–2008 | 4,371 | 4.06 (3.93–4.19) | 2,102 | 2.10 (2.01–2.20) | 2,247 | 1.92 (1.84–2.00) |
| 2009–2012 | 5,019 | 4.24 (4.12–4.36) | 2,425 | 2.19 (2.10–2.28) | 2,574 | 2.02 (1.94–2.11) |
| 2013–2016 | 5,982 | 4.74 (4.62–4.87) | 2,849 | 2.39 (2.30–2.48) | 3,122 | 2.34 (2.26–2.42) |
| APC | 2.10 | 1.40 | 2.98 | |||
| p-value | p<0.01 | p<0.01 | p<0.01 | |||
| NHB | ||||||
| 2001–2004 | 771 | 1.15 (1.07–1.24) | 482 | 0.73 (0.67–0.80) | 281 | 0.40 (0.35–0.45) |
| 2005–2008 | 874 | 1.25 (1.16–1.33) | 542 | 0.80 (0.73–0.87) | 323 | 0.44 (0.39–0.49) |
| 2009–2012 | 947 | 1.30 (1.21–1.38) | 587 | 0.83 (0.76–0.90) | 353 | 0.46 (0.41–0.51) |
| 2013–2016 | 1,036 | 1.36 (1.27–1.44) | 643 | 0.87 (0.80–0.94) | 385 | 0.47 (0.43–0.52) |
| APC | 1.28 | 1.37 | 1.28 | |||
| p-value | p<0.01 | p=0.01 | p=0.03 | |||
| A/PI | ||||||
| 2001–2004 | 408 | 1.39 (1.25–1.53) | 227 | 0.79 (0.69–0.90) | 181 | 0.60 (0.51–0.69) |
| 2005–2008 | 538 | 1.66 (1.52–1.81) | 306 | 0.97 (0.86–1.08) | 228 | 0.67 (0.58–0.77) |
| 2009–2012 | 656 | 1.77 (1.63–1.91) | 342 | 0.94 (0.85–1.05) | 311 | 0.81 (0.73–0.91) |
| 2013–2016 | 819 | 1.96 (1.83–2.10) | 440 | 1.07 (0.97–1.18) | 375 | 0.88 (0.79–0.97) |
| APC | 2.47 | 1.81 | 3.34 | |||
| p-value | p<0.01 | p=0.03 | p<0.01 | |||
| AI/AN | ||||||
| 2001–2004 | 208 | 3.00 (2.59–3.45) | 106 | 1.64 (1.34–2.00) | 101 | 1.34 (1.09–1.65) |
| 2005–2008 | 245 | 3.05 (2.67–3.48) | 122 | 1.60 (1.32–1.93) | 122 | 1.44 (1.19–1.74) |
| 2009–2012 | 288 | 3.15 (2.79–3.55) | 159 | 1.85 (1.57–2.18) | 129 | 1.30 (1.08–1.55) |
| 2013–2016 | 361 | 3.76 (3.37–4.18) | 191 | 2.14 (1.84–2.48) | 169 | 1.61 (1.37–1.88) |
| APC | 1.71 | 2.25 | 1.04 | |||
| p-value | p=0.03 | p=0.02 | p=0.29 | |||
†
Rates are per 100,000 and age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130)
Abbreviations: A/PI (Asian/Pacific Islander), AI/AN (American Indian/Alaska Native), APC (Annual Percent Change), CI (Confidence Interval), NHW (Non-Hispanic White), NHB (Non-Hispanic Black), US (United States), USCS (United States Cancer Statistics)